- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …and more efficiently.About the PositionWe are seeking a seasoned Staff Engineer to lead our AI Foundations Team-a new initiative dedicated to establishing the ... this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …bring new treatments to patients faster and more efficiently.Responsibilities Lead the design, development, and deployment of software solutions that leverage AI ... this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Lundbeck (Tarrytown, NY)
- …purpose to advance brain health and transform lives. Join us on our journey of growth !As a Psychiatry Account Manager, you lead the promotion of our psychiatry ... organizational goals, incorporating "total office" account management. Local Market & Therapeutic Area Expertise - Gather and validate key trends and dynamics in the… more
- Lundbeck (New York, NY)
- …advance brain health and transform lives. Join us on our journey of growth !BioPharmaceutical Regional Business Director - East Will consider candidates who live in ... KY.SUMMARY:The Regional Business Director (RBD) is responsible for leading field-based Area Sales Managers (ASM) and Biopharmaceutical Account Managers (BAM) to… more
- CBRE (New York, NY)
- …as a change agent for business improvements and develops buy-in and support for new initiatives and processes. *Effectively manage and lead team through change. ... Property Management Market Leader Job ID 191831 Posted 21-Feb-2025 Service line...Role type Full-time Areas of Interest Property Management Location(s) New York City - New York -… more
- Microsoft Corporation (New York, NY)
- …There is a different range applicable to specific work locations, within the San Francisco Bay area and New York City metropolitan area , and the base pay ... Join the Retail & Consumer Goods Organization as a **Global Strategic Sales Leader ** with our Microsoft Pepsico Team. In this role, you will oversee the development… more
- Stantec (New York, NY)
- …a long-term view of the industry, market, and client base. + Assist in the growth of ES by establishing new service areas. + Anticipate medium- and long-term ... Environmental Services - Sector Leader , Transmission & Distribution - ( 250000A9 )...**Description** Grounded in safety, quality, and ethics, our experts lead their fields and guide our work with rigor,… more
- Crate & Barrel (New York, NY)
- …The iconic look of our stores starts with you. Under the direction of the Store Leader , you lead the merchandising team to set the stage for an exceptional ... plans and strategies across the store and in assigned area . + Partner with the Store Leader ...Leader and other functional Assistant Store Leaders during new season planning and execution + Analyze results through… more
